Literature DB >> 15163636

Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.

Clelia T Storlazzi1, Thoas Fioretos, Kajsa Paulsson, Bodil Strömbeck, Carin Lassen, Tomas Ahlgren, Gunnar Juliusson, Felix Mitelman, Mariano Rocchi, Bertil Johansson.   

Abstract

Double minutes (dmin), the cytogenetic hallmark of genomic amplification, are found in approximately 1% of karyotypically abnormal acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS). The MYC gene at 8q24 has been reported to be amplified in the majority of the cases, and generally it has been assumed that MYC is the target gene. However, only a few studies have focused on the extent of the amplicon or on the expression patterns of the amplified genes. We have studied six cases (five AML and one MDS) with MYC-containing dmin. Detailed fluorescence in situ hybridization analyses identified a common 4.3 Mb amplicon, with clustered proximal and distal breakpoints, harboring eight known genes (C8FW, NSE2, POU5FLC20, MYC, PVT1, AK093424, MGC27434 and MLZE). The corresponding region was deleted in one of the chromosome 8 homologues in five of the six cases, suggesting that the dmin originated through extra replication (or loop-formation)--excision--amplification. Northern blot analysis revealed that MYC was not overexpressed. Instead, the C8FW gene, encoding a phosphoprotein regulated by mitogenic pathways, displayed increased expression. These results exclude MYC as the target gene and indicate that overexpression of C8FW may be the functionally important consequence of 8q24 amplicons in AML and MDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163636     DOI: 10.1093/hmg/ddh164

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

Review 1.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

2.  Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.

Authors:  Erick Riquelme; Milind B Suraokar; Jaime Rodriguez; Barbara Mino; Heather Y Lin; David C Rice; Anne Tsao; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

3.  Transformation by Tribbles homolog 2 (Trib2) requires both the Trib2 kinase domain and COP1 binding.

Authors:  Karen Keeshan; Will Bailis; Priya H Dedhia; Maria E Vega; Olga Shestova; Lanwei Xu; Kristin Toscano; Sacha N Uljon; Stephen C Blacklow; Warren S Pear
Journal:  Blood       Date:  2010-08-30       Impact factor: 22.113

4.  FLT3 Amplification as Double Minute Chromosomes in a Patient with Chronic Myelomonocytic Leukemia.

Authors:  Heyang Zhang; Xiaoxue Wang; Shibo Li; Xianfu Wang; Xianglan Lu; Ming Li; Hua Wang; Ying Liu; Hui Pang; Lijun Zhang
Journal:  Dis Markers       Date:  2021-06-05       Impact factor: 3.434

5.  Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.

Authors:  Giuseppe Matullo; Simonetta Guarrera; Marta Betti; Giovanni Fiorito; Daniela Ferrante; Floriana Voglino; Gemma Cadby; Cornelia Di Gaetano; Fabio Rosa; Alessia Russo; Ari Hirvonen; Elisabetta Casalone; Sara Tunesi; Marina Padoan; Mara Giordano; Anna Aspesi; Caterina Casadio; Francesco Ardissone; Enrico Ruffini; Pier Giacomo Betta; Roberta Libener; Roberto Guaschino; Ezio Piccolini; Monica Neri; Arthur W B Musk; Nicholas H de Klerk; Jennie Hui; John Beilby; Alan L James; Jenette Creaney; Bruce W Robinson; Sutapa Mukherjee; Lyle J Palmer; Dario Mirabelli; Donatella Ugolini; Stefano Bonassi; Corrado Magnani; Irma Dianzani
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  Amplification of c-MYC and MLL Genes as a Marker of Clonal Cell Progression in Patients with Myeloid Malignancy and Trisomy of Chromosomes 8 or 11.

Authors:  S Angelova; M Jordanova; B Spassov; V Shivarov; M Simeonova; I Christov; P Angelova; K Alexandrova; A Stoimenov; V Nikolova; I Dimova; P Ganeva; N Tzvetkov; E Hadjiev; S Toshkov
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

7.  Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.

Authors:  Tetsuo Hirano; Ryoko Yoshikawa; Hironori Harada; Yuka Harada; Atsuhiko Ishida; Takeshi Yamazaki
Journal:  Mol Cancer       Date:  2015-04-19       Impact factor: 27.401

8.  Genomic amplification of MYC as double minutes in a patient with APL-like leukemia.

Authors:  Pino J Poddighe; Hans Wessels; Pauline Merle; Marisa Westers; Shama Bhola; Anne Loonen; Sonja Zweegman; Gert J Ossenkoppele; Marielle J Wondergem
Journal:  Mol Cytogenet       Date:  2014-10-22       Impact factor: 2.009

9.  Episomal amplification of MYCN in a case of medulloblastoma.

Authors:  Cecilia Surace; Florence Pedeutour; Domenico Trombetta; Fanny Burel-Vandenbos; Mariano Rocchi; Clelia Tiziana Storlazzi
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.535

10.  De novo-generated small palindromes are characteristic of amplicon boundary junction of double minutes.

Authors:  Jing Zhu; Yang Yu; Xiangning Meng; Yihui Fan; Yu Zhang; Chunshui Zhou; Zhichao Yue; Yan Jin; Chunyu Zhang; Lisa Yu; Wei Ji; Xueyuan Jia; Rongwei Guan; Jie Wu; Jingcui Yu; Jing Bai; Xin-Yuan Guan; Mingrong Wang; Ki-Young Lee; Wenjing Sun; Songbin Fu
Journal:  Int J Cancer       Date:  2013-03-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.